Sign In
Buy NVS
$153.38
+4.45 (+2.99%)
At Close: Jun 23, 2026
Biohaven (BHVN) Stock Up on Spin-Off Transaction Finalization
02:54pm, Thursday, 06'th Oct 2022 Zacks Investment Research
The newly spun-off Biohaven Ltd. (BHVN) advances a portfolio of non-CGRP pipelines targeting neurological and neuropsychiatric indications.
Got $5,000? These 2 Stocks Are Bargain Buys Right Now
02:00pm, Thursday, 06'th Oct 2022 The Motley Fool
Whether you're looking for dividends or growth, Novartis and Paramount Global could be viable options for you.
5 Sleep Well At Night High-Yield Blue Chips Perfect For This Crazy Market
11:00am, Wednesday, 05'th Oct 2022 Seeking Alpha
Market's around the world have gone crazy, including UK bonds trading with 5X more volatility than Bitcoin. Read to find the most dependable high-yield, world-class blue chips.
Could This Biosimilar Drug Candidate Be a Hit for Novartis?
02:45pm, Monday, 03'rd Oct 2022 The Motley Fool
Novartis recently announced encouraging results from its clinical trial of its Prolia biosimilar.
Can Biogen (BIIB) Navigate Multiple Challenges & Grow Again?
01:15pm, Monday, 03'rd Oct 2022 Zacks Investment Research
Most of Biogen's (BIIB) key drugs are facing declining sales. Despite these challenges, we are hopeful that potential new product launches such as lecanemab, zuranolone and additional biosimilars can
Could This Biosimilar Drug Candidate Be a Hit for Novartis?
10:45am, Monday, 03'rd Oct 2022
Novartis recently announced encouraging results from its clinical trial of its Prolia biosimilar.
Why Moderna Was a Sickly Stock Today
10:20pm, Thursday, 29'th Sep 2022 The Motley Fool
A shuffle at the top of the executive ranks, combined with the continued decline of the coronavirus, rattles some investors.
NVS vs. RHHBY: Which Stock Should Value Investors Buy Now?
03:40pm, Thursday, 29'th Sep 2022 Zacks Investment Research
NVS vs. RHHBY: Which Stock Is the Better Value Option?
Is Novartis (NVS) a Great Value Stock Right Now?
01:40pm, Thursday, 29'th Sep 2022 Zacks Investment Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest
NVS vs. RHHBY: Which Stock Should Value Investors Buy Now?
12:47pm, Thursday, 29'th Sep 2022
NVS vs. RHHBY: Which Stock Is the Better Value Option?
Is Novartis (NVS) a Great Value Stock Right Now?
11:17am, Thursday, 29'th Sep 2022
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest
Is Biogen a Smart Biotech Stock to Buy Right Now?
09:13am, Thursday, 29'th Sep 2022 The Motley Fool
New clinical trial results are great, but this company's Alzheimer's disease program has deeply disappointed investors in the past.
Novartis's Strategic Plan Brings Many Plusses
05:03pm, Wednesday, 28'th Sep 2022
Novartis ( NVS , Financial) has launched some of the most novel therapeutics over the past five years, and yet it sells at just a few dollars above its 52-week low, has a trailing 12-month price-earni
How to Boost Your Portfolio with Top Medical Stocks Set to Beat Earnings
12:50pm, Monday, 26'th Sep 2022 Zacks Investment Research
The Zacks Earnings ESP is a great way to find potential earnings surprises. Why investors should take advantage now.
Start Buying This Week, I Explain, Why And How
04:44am, Monday, 26'th Sep 2022 Seeking Alpha
I have been trading in and out of my oil favorites in my trading account. Click here to see my weekly trades and why I've added Eli Lilly.
